Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.38
$0.0050.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.16M | -3.13M | -3.51M | 365.40K | -1.17M |
| Total Depreciation and Amortization | 22.20K | 21.60K | 21.00K | 20.50K | 20.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.40K | 60.40K | 432.60K | 60.40K | 62.00K |
| Change in Net Operating Assets | 155.90K | -123.60K | -17.60K | 277.50K | -2.01M |
| Cash from Operations | -2.91M | -3.17M | -3.07M | 723.80K | -3.09M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -12.00K | -- | -- |
| Cash from Investing | -- | 0.00 | -12.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.71M | -- | 3.01M | 56.00K | 3.84M |
| Repurchase of Common Stock | -- | -21.80K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -88.90K | -212.90K | -157.50K | -15.00K | -- |
| Cash from Financing | 7.62M | -234.70K | 2.85M | 41.00K | 3.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.71M | -3.40M | -231.90K | 764.80K | 747.10K |